Sino-Argi Leading Biosciences Financial Flexibility Index
Sino-Argi Leading Biosciences financial flexibility index. Sino-Argi Leading Biosciences (603970) has a Financial Flexibility Index of -0.08x as of September 2025. Free cash flow of CN¥-389.99 Million (operating CF CN¥-390.12 Million minus capex CN¥131.59K) represents 0% of total liabilities (CN¥4.85 Billion). See 603970 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Sino-Argi Leading Biosciences (2012–2025)
Financial flexibility index of Sino-Argi Leading Biosciences from 2012 to 2025. Historical Financial Flexibility Index trend for Sino-Argi Leading Biosciences across 14 annual periods. Check 603970 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Sino-Argi Leading Biosciences Financial Flexibility Index by Year (2012–2025)
Sino-Argi Leading Biosciences financial flexibility index by year from 2012 to 2025. Year-by-year free cash flow to debt coverage for Sino-Argi Leading Biosciences. For the full cash flow conversion analysis, see 603970 cash generation efficiency.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.02x | CN¥-76.94 Million | CN¥-78.31 Million | CN¥3.18 Billion | ▼ -130.6% |
| 2024 | 0.08x | CN¥309.58 Million | CN¥307.40 Million | CN¥3.92 Billion | ▲ +138.1% |
| 2023 | -0.21x | CN¥-915.48 Million | CN¥-919.85 Million | CN¥4.41 Billion | ▼ -164.1% |
| 2022 | 0.32x | CN¥1.54 Billion | CN¥1.54 Billion | CN¥4.76 Billion | ▲ +239.7% |
| 2021 | 0.10x | CN¥329.41 Million | CN¥325.42 Million | CN¥3.46 Billion | ▼ -25.3% |
| 2020 | 0.13x | CN¥367.11 Million | CN¥352.12 Million | CN¥2.88 Billion | ▼ -2.5% |
| 2019 | 0.13x | CN¥221.57 Million | CN¥218.90 Million | CN¥1.69 Billion | ▲ +184.9% |
| 2018 | 0.05x | CN¥74.68 Million | CN¥65.69 Million | CN¥1.63 Billion | ▼ -84.7% |
| 2017 | 0.30x | CN¥574.22 Million | CN¥518.83 Million | CN¥1.92 Billion | ▲ +240.7% |
| 2016 | 0.09x | CN¥189.06 Million | CN¥152.22 Million | CN¥2.15 Billion | ▲ +183.1% |
| 2015 | -0.11x | CN¥-229.91 Million | CN¥-254.22 Million | CN¥2.17 Billion | ▼ -479.3% |
| 2014 | 0.03x | CN¥46.59 Million | CN¥40.41 Million | CN¥1.67 Billion | ▲ +152.8% |
| 2013 | -0.05x | CN¥-73.61 Million | CN¥-79.66 Million | CN¥1.39 Billion | ▼ -147.2% |
| 2012 | 0.11x | CN¥111.17 Million | CN¥109.43 Million | CN¥991.46 Million | — |